• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Comprehensive Overview of tert-Butyl (3-((5-bromopyrimidin-2-yl)amino)propyl)carbamate (CAS No. 1289003-99-1)

tert-Butyl (3-((5-bromopyrimidin-2-yl)amino)propyl)carbamate (CAS No. 1289003-99-1) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This compound belongs to the class of pyrimidine derivatives, which are pivotal in drug discovery due to their structural versatility and biological relevance. The presence of a bromine substituent at the 5-position of the pyrimidine ring enhances its reactivity, making it a valuable intermediate for cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. Researchers frequently employ this compound in the development of kinase inhibitors, antiviral agents, and other bioactive molecules.

In recent years, the demand for high-purity intermediates like tert-Butyl (3-((5-bromopyrimidin-2-yl)amino)propyl)carbamate has surged, driven by advancements in precision medicine and targeted therapy. The compound's carbamate and aminoalkyl functionalities contribute to its stability and solubility, addressing key challenges in formulation development. Its CAS No. 1289003-99-1 is often searched in databases like SciFinder and Reaxys, reflecting its importance in academic and industrial settings. Additionally, its structural features align with trends in fragment-based drug design, a hot topic in modern medicinal chemistry.

From a synthetic perspective, tert-Butyl (3-((5-bromopyrimidin-2-yl)amino)propyl)carbamate serves as a building block for heterocyclic scaffolds. The tert-butyloxycarbonyl (Boc) protecting group is particularly advantageous, as it can be selectively removed under mild acidic conditions without affecting the pyrimidine core. This property is critical for multi-step syntheses, where orthogonal protection strategies are required. The compound's 5-bromopyrimidine moiety also enables late-stage diversification via palladium-catalyzed reactions, a technique frequently discussed in green chemistry forums due to its atom efficiency.

The growing interest in small-molecule therapeutics has further elevated the relevance of CAS No. 1289003-99-1. For instance, its derivatives are explored in cancer immunotherapy and neurodegenerative disease research, areas garnering significant attention in 2023. Analytical techniques such as HPLC-MS and NMR are routinely used to verify its purity, ensuring compliance with Good Manufacturing Practice (GMP) standards. Furthermore, the compound's structure-activity relationship (SAR) studies are frequently cited in patents, highlighting its commercial potential.

In conclusion, tert-Butyl (3-((5-bromopyrimidin-2-yl)amino)propyl)carbamate (CAS No. 1289003-99-1) exemplifies the intersection of chemical innovation and biomedical application. Its adaptability in diverse synthetic pathways and alignment with cutting-edge research trends make it indispensable for scientists tackling global health challenges. As the pharmaceutical industry shifts toward personalized therapies, compounds like this will continue to play a central role in shaping the future of drug development.

• 193473-64-2(tert-Butyl (2-(Pyrimidin-2-ylamino)ethyl)carbamate)
• 1030389-08-2(3-(5-bromo-pyrimidin-2-ylamino)-piperidine-1-carboxylic acid tert-butyl ester)
• 1215205-89-2(5-Bromo-2-(N-BOC-N-cyclopropylaminopyrimidine)
• 1272973-74-6(Tert-butyl 4-(5-bromopyrimidin-2-yl)-3-methylpiperazine-1-carboxylate)
• 1448854-60-1((1R*,4R*)-Tert-Butyl N-[4-(pyrimidin-2-ylamino)cyclohexyl]carbamate)
• 1272973-71-3(Tert-butyl (3S)-4-(5-bromo-2-pyrimidinyl)-3-methyl-1-piperazinecarboxylate)
• 374930-88-8(Tert-butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate)
• 1289192-03-5(tert-Butyl 1-(5-bromopyrimidin-2-yl)piperidin-4-ylcarbamate)
• 2680782-66-3(tert-butyl N-{2-benzyl(5-bromopyrimidin-2-yl)aminoethyl}carbamate)
• 883231-23-0(2-(N-BOC-Amino)-5-bromopyrimidine)